03.02.23 -- Establishing Your Clinical Supply Strategy

Supply chains are becoming more complex. Planning for commercial launch early in development and working with a partner with specialist packaging design capabilities and experience across the development-to-commercial launch cycle may reduce potential risks and associated costs.

Aspects of accountability, reconciliation, return, and destruction should be part of the drug supply planning process. Yet this is often overlooked, and significant effort is required to compile historical data. A little up-front planning helps to avoid difficulty and can remove many future complications.

Exponential growth is expected in the clinical trials supply and logistics market, which places huge pressure on drug discovery companies, CROs, and CDMOs to find supply management solutions that ensure seamless, efficient delivery of clinical trial materials while navigating the challenges of more complex study designs and the ever-evolving regulatory landscape.

Biopharmaceutical drug development remains a key trend, demanding specific expertise and capabilities when it comes to quality assurance. Explore four areas in biologics that appear to be major talking points for customers and therefore are fundamentally important.

In this roundtable, experts run through a recent project to create a best-in-class clinical- to commercial-scale potent packaging suite by discussing the attention to technical detail required to ensure that the required high standards and regulatory controls were not only met but exceeded.